Introduction
Despite developments in antimicrobial agents and intensive care units, meningitis as well as nosocomial or healthcare-associated meningitis (HCAM) is still associated with significant mortality and morbidity (1) (2) (3) . Several studies of epidemiological or clinical features and prognostic factors in adults with HCAM have been performed; however, nearly all are retrospective and relatively small in size and many are from developed countries (4) (5) (6) (7) (8) . Studies from Turkey are also retrospective and have the disadvantage of low patient numbers . The aim of this study was to systematically review the medical literature from Turkey for acute adult purulent meningitis between 1998 and 2013.
Materials and methods
To perform the review, published series were searched in one national database, the ULAKBİM Turkish medical literature database (http://uvt.ulakbim.gov.tr/uvt/), and two international databases (www.scopus.com and www. pubmed.com). In addition to these databases, abstracts of congresses held between 2004 and 2013 by the Turkish Clinical Microbiology and Infectious Diseases Specialists Association (Turkish acronym: EKMUD), the Turkish Clinical Microbiology and Infectious Diseases Association (KLİMİK), the Antibiotic and Chemotherapy Association (ANKEM), and the Turkish Society of Hospital Infection Control and Prevention (HİDER) were searched for reports of nosocomial meningitis. For a more comprehensive review, articles cited in references from these sources have also been included. The key word for the national database was 'meningitis' . Key words used for Scopus and PubMed were 'meningitis and Turkey and (nosocomial or healthcare associated or hospital acquired)' . All abstracts found in databases or congress proceeding books were analyzed by two separate investigators.
For studies that were both published and presented at congresses, only the published article was taken into consideration. In the case of presentations from a single study with overlapping periods, the study covering the longer duration was chosen. The following articles were excluded: 1) articles published before 1998; 2) communityacquired meningitis series; 3) chronic meningitis case reports/series; 4) aseptic meningitis series; 5) chronic meningitis series; 6) case reports or series with less than 5 patients, and 7) pediatric series.
Results
Data for 858 patients with a diagnosis of 899 nosocomial meningitis episodes were obtained from 24 reports (19 articles, 5 congress abstracts) in our study . All reports used the CDC criteria for nosocomial meningitis (33) . Of the 19 published articles, nine were in peer-reviewed medical journals indexed in national databases and 10 in peer-reviewed journals indexed in international databases.
Sex was reported for 583 patients (45.1% female, 54.9% male). The pooled mean age was 26.5 (n = 795). As underlying diseases, 27.9% (188/672) had intracranial mass, 17.2% (111/642) had intracranial bleeding, 6.2% (35/565) had aneurysms, and 8.4% (57/682) had trauma. Additionally, 32.8% (109/332) had a coinfection in another body site.
In terms of clinical findings, 177 out of 216 (81.9%) had fever (>38 °C) and 23 out of 103 (22.3%) had headache. Twenty-seven out of 111 (24.3%) had stiffness of the neck. In addition, 72 out of 112 (64.2%) had vomiting or nausea. Disturbances of consciousness were present in 78 out of 116 (67.2%), while 85.9% (55/64) had high CRP levels and 105 of 132 (79.5%) had leukocytosis (>10,000/mm 3 ). Furthermore, 31.8% (241 of 759) had shunt infection.
Cerebrospinal fluid culture yielded a pathogen in 79% (689/872) of the nosocomial meningitis episodes (Table) . In addition, 22.5% had concomitant bacteremia. The most common pathogen was Acinetobacter spp. (30.7%), followed by coagulase-negative staphylococci (21.2%) and S. aureus (19%). Gram staining was reported to be positive in 23 out of 58 (39.6%) cases. Carbapenem resistance was reported in 18 of 48 (37.5%) Acinetobacter spp. meningitis strains. About 61% (47/77) of S. aureus and 80.6% (29/36) S. epidermidis meningitis episodes were methicillinresistant. In 78.1% of shunt infections (100/128) the shunt was removed during the management. Overall mortality was 27% (160/593). Pathogen-specific mortality was 55.5% (30/54) for A. baumannii whereas it was 18.9% (7/37) for S. aureus and 2/17 (11.7%) for MRSA.
Discussion
Although HCAM is a relatively small part of healthcareassociated infections (34) , it may result in severe consequences such as significant morbidity and mortality. Durand et al. (4) reported that HCAM accounted for 40% of 495 acute bacterial meningitis episodes in a 27-year period. This rate may increase in centers with a higher number of invasive hospital practices.
In contrast to community-acquired acute purulent meningitis, where pneumococci and meningococci are the dominating pathogens (1-3), the major causative agents in HCAM are usually gram-negative bacilli including Pseudomonas aeruginosa, Acinetobacter spp., or Enterobacteriaceae and gram-positive cocci such as staphylococci or enterococci. The overall rate of etiological agents yielded by bacterial cultures is also higher in nosocomial meningitis than community-acquired meningitis (35) , which is probably due to the fact that the 
Staphylococcus aureus 131

Pseudomonas aeruginosa 35
Klebsiella spp. 35
Escherichia coli 35
Enterobacter spp. 27
Enterococcus spp. 24
Candida spp. 18
Streptococcus pneumoniae 9
Stenotrophomonas maltophilia 5
Serratia marcescens 4
Citrobacter spp. 2
Burkholderia spp. 2 Beta-hemolytic streptococci 2
Brucella spp. 2
Flavobacterium odoratum 1
Achromobacter xylosoxidans 1
Morganella morganii 1
Aeromonas hydrophila 1
Proteus spp. 1
Corynebacterium amycolatum 1
Haemophilus influenzae 1
Kluyvera spp. 1
Hafnia alvei 1
Aspergillus spp. 1
Total 699 *Ten cases had mixed infections.
common bacteria are easier to grow and they are usually multidrug-resistant, less inhibited by the antibiotics used commonly in the community. In the presented study, overall mortality was 27%, comparable to other nosocomial meningitis series (5, 6, 8) .
The most common bacterial agent causing HCAM differs from country to country: in the Netherlands, pneumococci (5); MRSA in Taiwan (6); E. coli in the United States (4); coagulase-negative staphylococci in Korea (8) ; and MSSA in France (7). These major differences are probably due to infection control measures and/or the spectrum of neurosurgical operation types. In the presented study the most common etiologic agent was Acinetobacter spp. In Turkey Acinetobacter spp. and S. aureus are among the most common causes of overall healthcare-associated infections in many hospitals.
In our study the pooled carbapenem resistance rate was 37.5% and the methicillin resistance rate in coagulasenegative staphylococci was 81%. In addition, carbapenemresistant A. baumannii and MRSA are endemic in many hospitals. Fifty-percentile carbapenem resistance rate in A. baumannii and MRSA strains causing healthcare-associated infections in Turkish tertiary-care educational university hospitals were 87.3% and 43.2% in 2012, respectively (http://www.saglikaktuel.com/d/file/uhesa-analiz-2012. pdf). Fifty-percentile carbapenem-resistant strains are almost always resistant to the commonly used first-line antimicrobial agents ceftazidime, cefepime, and meropenem in the empirical treatment of HCAM (1) (2) (3) 36, 37) . This is probably the reason for the quite high mortality of 55.5% in carbapenem-resistant A. baumannii meningitis, which also suggests colistin as a first-line therapy in empirical antibiotherapy. Probably since first-line empirical therapy usually includes vancomycin (1-3), the mortality rate of vancomycin was lower in MRSA meningitis (11.7%).
In the presented study, two cases of Brucella spp. HCAM were reported. Brucella spp. infections as well as neurobrucellosis are endemic in Turkey (38, 39) . Recently, Mermer et al. also reported a Brucella spp. shunt infection (39) . As with the two cases reported in this pooled analysis, we can suggest that one should keep in mind the possibility of shunt infections with such organisms in communities with certain endemic infections such as brucellosis (40) .
When we compared our results in terms of symptoms with the results of a pooled analysis of nonnosocomial adult acute purulent meningitis (35) , fever (81.9% vs.
79.8%), disturbances of consciousness (67.2% vs. 57.6%), nausea (64.2% vs. 69.7%), and leukocytosis (79.5% vs. 82.7%) were nearly as common. However, neck stiffness (24.5% vs. 89.8%) and headache (22.3% vs. 88.2%) were lower, which is probably due to the predominance of shunt infections or CSF leakage, which does not cause a prominent increase in the cerebrospinal fluid pressure (2, 35) .
Pooled analysis is advantageous in understanding the epidemiology of rare diseases and syndromes such as fever of unknown origin, meningitis, and mucormycosis (35) (36) (37) (38) (39) (40) (41) (42) . While pooling the data, the inclusion criteria are important. Retrospective studies have the disadvantage of depending on retrospective hospital records. Although the studies included in this pooled analysis used the CDC definitions (33) for nosocomial meningitis, they all used retrospective clinical data. Another important disadvantage of our study is the heterogeneity of the data. Because of this heterogeneity, the ratios in different variables have different denominators. Although all centers were tertiary-care educational hospitals, possible double reports of a single patient from two different centers cannot be excluded. Since abstracts of the congresses held before 2004 could not be reached thoroughly, abstracts between 1998 and 2003 could not be included in the study. In spite of these disadvantages, to our knowledge this is the first pooled analysis on this topic gathering the most data and major clues about the epidemiology and clinical findings in HCAM in Turkey as well as the world.
In conclusion, the presented data show that HCAM is associated with 27% mortality. Acinetobacter spp. seem to be the most important pathogens in HCAM in Turkey. Carbapenem-resistant A. baumannii meningitis is associated with a mortality of 55.5% and MRSA with 11.7%. Hence, colistin may be an important antibiotic in centers with high carbapenem resistance rates. In order to identify epidemiologic changes, it is necessary to create an appropriate national registration system with fewer bureaucratic entities. Finally, effective infection control measures regarding prevention of HCAM are urgently needed.
